Repligen Corporation - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
RGEN Nasdaq 2836 www.repligen.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Repligen Corporation

3 Healthcare Stocks That Concern Us - Oct 2nd, 2026 5:02 am
Why Did KOD, RGEN, BIIB Stocks Rise To 52-Week Highs? - Sep 28th, 2026 10:23 pm
Merck's Remigromig Meets Main Goal in Diabetic Macular Edema Study - Sep 25th, 2026 8:19 am
AMGN's Dazodalibep Meets Goal in Systemic Sjogren's Disease Study - Sep 23rd, 2026 8:38 am
3 Unpopular Stocks Walking a Fine Line - Sep 23rd, 2026 3:17 am
Alkermes Posts Positive Data From Phase I ADHD Study on ALKS 7290 - Sep 22nd, 2026 9:15 am
JNJ's Caplyta Shows Benefit in Bipolar 1 Related Mania Study - Sep 22nd, 2026 9:13 am
NVS Gets Positive CHMP Opinion for Cosentyx for Another Indication - Sep 21st, 2026 9:57 am
Merck Gets CHMP Backing for Keytruda-Padcev Combo in Bladder Cancer - Sep 21st, 2026 9:27 am
CHMP Backs CORT's Lifyorli Combo in Platinum-Resistant Ovarian Cancer - Sep 21st, 2026 9:07 am
PBYI's Alisertib Combo Phase II Study in Small Cell Lung Cancer Begins - Sep 18th, 2026 8:48 am
RHHBY's Lunsumio Combo Meets Goal in 2L Follicular Lymphoma Study - Sep 17th, 2026 8:48 am
RCKT Aligns With FDA on Completing Phase II Study in Danon Disease - Sep 16th, 2026 8:56 am
Roche Gets FDA Priority Tag for Enspryng in Rare Autoimmune Disorder - Sep 10th, 2026 9:42 am
3 Reasons to Avoid RGEN and 1 Stock to Buy Instead - Sep 9th, 2026 1:14 pm
Novartis' Del-desiran Fails Late-Stage DM1 Study, Shares Fall - Sep 9th, 2026 12:47 pm
FDA Accepts & Gives Priority Review to Intellia's BLA for HAE Drug - Sep 9th, 2026 8:05 am
ABBV's Etentamig Meets Goals in Phase III Multiple Myeloma Study - Sep 4th, 2026 8:48 am
Repligen (RGEN) Stock Looks Near Fair Value After Recent Rebound - Sep 4th, 2026 12:20 am